A Detailed Analysis of the Peripherally Inserted Central Catheter (PICC) Market by Conventional and Neonatal PICC, from 2024 to 2034

<p>The global <strong>peripherally inserted central catheter market </strong>size is estimated to reach US$ 1,037.0 million in 2024. Over the projection period, global demand for peripherally inserted central catheters (PICCs) is anticipated to rise at a CAGR of 2.2%. By 2034, global peripherally inserted central catheter revenue is set to total US$ 1,289.8 million.</p><table><tbody><tr><th scope='row'>Attributes</th><td>Key Insights</td></tr><tr><th scope='row'>Based Market Value (2023)</th><td>US$ 1,008.5 million</td></tr><tr><th scope='row'>Estimated Peripherally Inserted Central Catheter Market Size (2024)</th><td>US$ 1,037.0 million</td></tr><tr><th scope='row'>Projected Market Value (2034)</th><td>US$ 1,289.9 million</td></tr><tr><th scope='row'>Value CAGR (2024 to 2034)</th><td>2.2%</td></tr></tbody></table><p>Historical Performance Vs Peripherally Inserted Central Catheter (PICC) Market Forecast</p><table><tbody><tr><th scope='row'>Historical CAGR (2019 to 2023)</th><td>2.1%</td></tr><tr><th scope='row'>Forecast CAGR (2024 to 2034)</th><td>2.2%</td></tr></tbody></table><p>Country-wise Insights</p><table><tbody><tr><th scope='row'>Countries</th><td>Value CAGR</td></tr><tr><th scope='row'>United States</th><td>1.2%</td></tr><tr><th scope='row'>Germany</th><td>1.2%</td></tr><tr><th scope='row'>United Kingdom</th><td>1.6%</td></tr><tr><th scope='row'>China</th><td>5.5%</td></tr><tr><th scope='row'>India</th><td>5.6%</td></tr></tbody></table><p>Category-wise Insights</p><table><tbody><tr><th scope='row'>Product</th><td>Value CAGR</td></tr><tr><th scope='row'>Conventional PICC</th><td>0.8%</td></tr><tr><th scope='row'>Power Injected PICC</th><td>2.2%</td></tr><tr><th scope='row'>Neonatal PICC</th><td>4.4%</td></tr></tbody></table><table><tbody><tr><th scope='row'>Product</th><td>Value CAGR</td></tr><tr><th scope='row'>Single Lumen</th><td>1.4%</td></tr><tr><th scope='row'>Double Lumen</th><td>3.0%</td></tr><tr><th scope='row'>Multiple Lumen</th><td>2.0%</td></tr></tbody></table><table><tbody><tr><th scope='row'>Application</th><td>Value CAGR</td></tr><tr><th scope='row'>Chemotherapy</th><td>4.7%</td></tr><tr><th scope='row'>Long-term IV Infusion</th><td>0.8%</td></tr><tr><th scope='row'>Parenteral Nutrition</th><td>4.1%</td></tr><tr><th scope='row'>Blood Transfusion</th><td>5.5%</td></tr><tr><th scope='row'>Difficult Intravenous Access</th><td>1.3%</td></tr><tr><th scope='row'>Others</th><td>2.2%</td></tr></tbody></table><table><tbody><tr><th scope='row'>End User</th><td>Value CAGR</td></tr><tr><th scope='row'>Hospitals</th><td>0.7%</td></tr><tr><th scope='row'>Cancer Research Institutes</th><td>5.4%</td></tr><tr><th scope='row'>Long Term Care Centers</th><td>3.5%</td></tr><tr><th scope='row'>Independent Infusion Centers</th><td>3.8%</td></tr><tr><th scope='row'>Ambulatory Surgical Center</th><td>1.6%</td></tr><tr><th scope='row'>Home Care Settings</th><td>2.3%</td></tr></tbody></table>

<p>全球外周置入中心静脉导管市场之规模预计于2024年达到10.37亿美元。在预测期内，全球对外周置入中心静脉导管（PICC）的需求预计将以2.2%的复合年增长率增长。至2034年，全球外周置入中心静脉导管的收入预计将累计达到12.898亿美元。</p><table><tbody><tr><th scope='row'>属性</th><td>关键洞察</td></tr><tr><th scope='row'>基于市场价值（2023年）</th><td>10.085亿美元</td></tr><tr><th scope='row'>预计外周置入中心静脉导管市场规模（2024年）</th><td>10.37亿美元</td></tr><tr><th scope='row'>预测市场价值（2034年）</th><td>12.899亿美元</td></tr><tr><th scope='row'>价值复合年增长率（2024年至2034年）</th><td>2.2%</td></tr></tbody></table><p>历史表现与外周置入中心静脉导管（PICC）市场预测对比</p><table><tbody><tr><th scope='row'>历史复合年增长率（2019年至2023年）</th><td>2.1%</td></tr><tr><th scope='row'>预测复合年增长率（2024年至2034年）</th><td>2.2%</td></tr></tbody></table><p>按国家划分的洞察</p><table><tbody><tr><th scope='row'>国家</th><td>价值复合年增长率</td></tr><tr><th scope='row'>美国</th><td>1.2%</td></tr><tr><th scope='row'>德国</th><td>1.2%</td></tr><tr><th scope='row'>英国</th><td>1.6%</td></tr><tr><th scope='row'>中国</th><td>5.5%</td></tr><tr><th scope='row'>印度</th><td>5.6%</td></tr></tbody></table><p>按类别划分的洞察</p><table><tbody><tr><th scope='row'>产品</th><td>价值复合年增长率</td></tr><tr><th scope='row'>传统PICC</th><td>0.8%</td></tr><tr><th scope='row'>动力注射PICC</th><td>2.2%</td></tr><tr><th scope='row'>新生儿PICC</th><td>4.4%</td></tr></tbody></table><table><tbody><tr><th scope='row'>产品</th><td>价值复合年增长率</td></tr><tr><th scope='row'>单腔</th><td>1.4%</td></tr><tr><th scope='row'>双腔</th><td>3.0%</td></tr><tr><th scope='row'>多腔</th><td>2.0%</td></tr></tbody></table><table><tbody><tr><th scope='row'>应用</th><td>价值复合年增长率</td></tr><tr><th scope='row'>化疗</th><td>4.7%</td></tr><tr><th scope='row'>长期静脉输液</th><td>0.8%</td></tr><tr><th scope='row'>肠外营养</th><td>4.1%</td></tr><tr><th scope='row'>输血</th><td>5.5%</td></tr><tr><th scope='row'>困难静脉通路</th><td>1.3%</td></tr><tr><th scope='row'>其他</th><td>2.2%</td></tr></tbody></table><table><tbody><tr><th scope='row'>终端用户</th><td>价值复合年增长率</td></tr><tr><th scope='row'>医院</th><td>0.7%</td></tr><tr><th scope='row'>癌症研究机构</th><td>5.4%</td></tr><tr><th scope='row'>长期护理中心</th><td>3.5%</td></tr><tr><th scope='row'>独立输液中心</th><td>3.8%</td></tr><tr><th scope='row'>门诊手术中心</th><td>1.6%</td></tr><tr><th scope='row'>家庭护理环境</th><td>2.3%</td></tr></tbody></table>